Skip to main content

What Is Cystic Fibrosis? The Relationship Between Nutrition and Outcomes in Cystic Fibrosis

  • Chapter
Nutrition in Cystic Fibrosis

Part of the book series: Nutrition and Health ((NH))

  • 1694 Accesses

Abstract

Cystic fibrosis (CF) is the most common life-shortening inherited disease in the USA, affecting approximately 30,000 children and adults. This autosomal recessive disorder is caused by mutations in the gene encoding the cystic fibrosis transmembrane regulator (CFTR) (Riordan et al., Science 245:1066–1073, 1989). CFTR is an ion channel that is present in multiple organs throughout the body. Mutations in this gene are divided into five major categories. Class I, II, and III mutations generally result in more severe pulmonary disease and pancreatic insufficiency; CF patients with these mutations generally have symptomatic disease in infancy or childhood. Class IV and V mutations typically result in milder disease, which is often diagnosed later in life (O’Sullivan and Freedman, Lancet 373:1891–1904, 2009). Neonatal screening catches most patients in the USA with diagnosis confirmed by sweat or genetic testing. Diagnosis in the neonatal period leads to opportunities to optimize nutrition earlier in life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–73.

    Article  CAS  PubMed  Google Scholar 

  2. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–904.

    Article  PubMed  Google Scholar 

  3. Busch R. On the history of cystic fibrosis. Acta Univ Carol Med. 1990;36(1–4):13–5.

    CAS  Google Scholar 

  4. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child. 1938;56(2):344–99.

    Article  Google Scholar 

  5. Anthony H, Bines J, Phelan P, Paxton S. Relation between dietary intake and nutritional status in cystic fibrosis. Arch Dis Child. 1998;78(5):443–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Cystic Fibrosis Foundation. Patient Registry 2011: Annual Report. Bethesda, MD: Cystic Fibrosis Foundation 2011.

    Google Scholar 

  7. Waters DL, Dorney SF, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med. 1990;322(5):303–8.

    Article  CAS  PubMed  Google Scholar 

  8. Bronstein MN, Sokol RJ, Abman SH, Chatfield BA, Hammond KB, Hambidge KM, et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr. 1992;120(4 Pt 1):533–40.

    Article  CAS  PubMed  Google Scholar 

  9. Couper RT, Corey M, Moore DJ, Fisher LJ, Forstner GG, Durie PR. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res. 1992;32(2):179–82.

    Article  CAS  PubMed  Google Scholar 

  10. Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;10, CD008227.

    PubMed  Google Scholar 

  11. Harris R, Norman AP, Payne WW. The effect of pancreatin therapy on fat absorption and nitrogen retention in children with fibrocystic disease of the pancreas. Arch Dis Child. 1955;30(153):424–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Allan JD, Milner J, Moss D. Therapeutic use of an artificial diet. Lancet. 1970;1(7650):785–6.

    Article  CAS  PubMed  Google Scholar 

  13. Allan JD, Mason A, Moss AD. Nutritional supplementation in treatment of cystic fibrosis of the pancreas. Am J Dis Child. 1973;126(1):22–6.

    CAS  PubMed  Google Scholar 

  14. Berry HK, Kellogg FW, Hunt MM, Ingberg RL, Richter L, Gutjahr C. Dietary supplement and nutrition in children with cystic fibrosis. Am J Dis Child. 1975;129(2):165–71.

    CAS  PubMed  Google Scholar 

  15. Graham DY. Pancreatic enzyme replacement: the effect of antacids or cimetidine. Dig Dis Sci. 1982;27(6):485–90.

    Article  CAS  PubMed  Google Scholar 

  16. Crozier DN. Cystic fibrosis: a not-so-fatal disease. Pediatr Clin North Am. 1974;21(4):935–50.

    CAS  PubMed  Google Scholar 

  17. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–91.

    Article  CAS  PubMed  Google Scholar 

  18. Ramsey BW, Farrell PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr. 1992;55(1):108–16.

    CAS  PubMed  Google Scholar 

  19. Chase HP, Long MA, Lavin MH. Cystic fibrosis and malnutrition. J Pediatr. 1979;95(3):337–47.

    Article  CAS  PubMed  Google Scholar 

  20. Phelan PD, Allan JL, Landau LI, Barnes GL. Improved survival of patients with cystic fibrosis. Med J Aust. 1979;1(7):261–3.

    CAS  PubMed  Google Scholar 

  21. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187–91.

    Article  CAS  PubMed  Google Scholar 

  22. Efrati O, Mei-Zahav M, Rivlin J, Kerem E, Blau H, Barak A, et al. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease. J Pediatr Gastroenterol Nutr. 2006;42(2):222–8.

    Article  PubMed  Google Scholar 

  23. Walker SA, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. J Pediatr Gastroenterol Nutr. 1998;27(1):53–6.

    Article  CAS  PubMed  Google Scholar 

  24. Marcotte JE, Canny GJ, Grisdale R, Desmond K, Corey M, Zinman R, et al. Effects of nutritional status on exercise performance in advanced cystic fibrosis. Chest. 1986;90(3):375–9.

    Article  CAS  PubMed  Google Scholar 

  25. Augarten A, Akons H, Aviram M, Bentur L, Blau H, Picard E, et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant. 2001;5(5):339–42.

    Article  CAS  PubMed  Google Scholar 

  26. Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc. 2001;101(4):438–42.

    Article  CAS  PubMed  Google Scholar 

  27. Dalzell AM, Shepherd RW, Dean B, Cleghorn GJ, Holt TL, Francis PJ. Nutritional rehabilitation in cystic fibrosis: a 5 year follow-up study. J Pediatr Gastroenterol Nutr. 1992;15(2):141–5.

    Article  CAS  PubMed  Google Scholar 

  28. George L, Norman AP. Life tables for cystic fibrosis. Arch Dis Child. 1971;46(246):139–43.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003;142(6):624–30.

    Article  PubMed  Google Scholar 

  30. Peterson ML, Jacobs Jr DR, Milla CE. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics. 2003;112(3 Pt 1):588–92.

    Article  PubMed  Google Scholar 

  31. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153(4):345–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr. 2000;137(3):374–80.

    Article  CAS  PubMed  Google Scholar 

  33. Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax. 2002;57(7):596–601.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008;153(6):752–7.

    Article  PubMed  Google Scholar 

  35. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107(1):1–13.

    Article  CAS  PubMed  Google Scholar 

  36. Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol. 2003;35(5):342–9.

    Article  CAS  PubMed  Google Scholar 

  37. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A, et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics. 2007;119(1):19–28.

    Article  PubMed  Google Scholar 

  38. Rao L, Tiller C, Coates C, Kimmel R, Applegate KE, Granroth-Cook J, et al. Lung growth in infants and toddlers assessed by multi-slice computed tomography. Acad Radiol. 2010;17(9):1128–35.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Gaultier C. Malnutrition and lung growth. Pediatr Pulmonol. 1991;10(4):278–86.

    Article  CAS  PubMed  Google Scholar 

  40. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35(3):246–59.

    Article  PubMed  Google Scholar 

  41. Poustie VJ, Watling RM, Ashby D, Smyth RL. Reliability of percentage ideal weight for height. Arch Dis Child. 2000;83(2):183–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG, et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr. 1998;132(3 Pt 1):478–85.

    Article  CAS  PubMed  Google Scholar 

  43. Zhang Z, Lai HJ. Comparison of the use of body mass index percentiles and percentage of ideal body weight to screen for malnutrition in children with cystic fibrosis. Am J Clin Nutr. 2004;80(4):982–91.

    CAS  PubMed  Google Scholar 

  44. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H, Clinical Practice Guidelines on Growth and Nutrition Subcommittee, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832–9.

    Article  PubMed  Google Scholar 

  45. Lai HJ, Shoff SM, Farrell PM, Wisconsin Cystic Fibrosis Neonatal Screening Group. Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis. Pediatrics. 2009;123(2):714–22.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Assael BM, Casazza G, Iansa P, Volpi S, Milani S. Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening. Pediatr Pulmonol. 2009;44(3):209–15.

    Article  PubMed  Google Scholar 

  47. Yen EH, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162(3):530–535. e1.

    Google Scholar 

  48. Wang X, Dockery DW, Wypij D, Fay ME, Ferris Jr BG. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol. 1993;15(2):75–88.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Danielle Usatin M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Usatin, D., Yen, E.H. (2015). What Is Cystic Fibrosis? The Relationship Between Nutrition and Outcomes in Cystic Fibrosis. In: Yen, E., Leonard, A. (eds) Nutrition in Cystic Fibrosis. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-16387-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16387-1_1

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-16386-4

  • Online ISBN: 978-3-319-16387-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics